Gaucher Disease: A First Reported Adult Case in Indonesia

Ardhi Rahman Ahani, Cosphiadi Irawan, Agnes Stephanie Harahap, Klara Yuliarti, Maria Francisca Ham, Faramitha Nur Izzaty, Damayanti Rusli Sjarif

Abstract


A 44-year-old female presented with a distended abdomen and fatigue. On physical examination, prominent splenomegaly was found. The laboratory investigations revealed pancytopenia and decreased albumin-globulin ratio. The abdominal ultrasonography revealed splenomegaly, cholelithiasis, and cystitis, and the bone survey showed osteopenia. Differential diagnoses included leukemia, multiple myeloma, and myelofibrosis therefore bone marrow puncture was performed. However, histopathologic examination found Gaucher-like cells in the bone marrow aspiration. The finding of CD68 positivity in Gaucher-like cells by using the immunohistochemistry staining supporting Gaucher disease. To confirm the diagnosis, an examination of glucocerebroside substrate from the patient’s blood plasma was performed. Glucosylsphingosine, a deacylated form of glucosylceramide, was markedly elevated. Therefore, the diagnosis of Gaucher disease was confirmed. This is the first reported adult Gaucher case diagnosed in Indonesia.


Keywords


Gaucher Disease; Splenomegaly; Pancytopenia

References


Cormand B, Montfort M, Chabas A, Vilageliu L, Grinberg D. Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes; implication for Gaucher diseases. Hum Genet. 1997;100(1):75.

Beutler E, Grabowski GA. Gaucher diseases. New York: McGraw-Hill; 2001.

Dionisi-Vici C, Rizzo C, Burlina AB, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr. 2002;140:321-7.

Nascimbeni F, Vici CD, Gentilucci UV, et al. AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement. Digestive and Liver Disease. 2020;52:359-67.

Linari S, Castaman G. Hematological manifestations and complications of Gaucher disease. Expert Rev Hematol. 2015;9(1):51-8.

Giuffrida G, Cappelini MD, Carubbi F, Di Rocco M, G L. Management of bone disease in Gaucher disease type I: Clinical Practice. Adv Ther. 2014:1-16.

Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutation in Parkinson’s disease. N Eng J Med. 2009;361:1651-61.

Lo MS, Liu J, Chen F, et al. Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy. J Inherit Metab Dis. 2011;34(3):643-50.

Weinreb NJ, Mistry PK, Rosenbloom BE, MV D. MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association. Blood. 2018;131(22):2500-1.

Taddei TH, Dziura J, Chen S, et al. High incidence of cholesterol gallstone disease in type I Gaucher disease: characterizing the biliary phenotype of type I Gaucher disease. J Inherit Metab Dis. 2010;33:291-300.

Shenjere P, Roy A, Eyden B, Banerjee SS. Pseudo-Gaucher cells in multiple myeloma. Int J Surg Pathol. 2008;16:176-9.

Bajaj P, Kasture J, BS S. Gaucher’s disease - A case report. MVP J Med Sci. 2015;2:130-1.

Costello R OCT, Sébahoun G. Gaucher disease and multiple myeloma. Leuk Lymphoma. 2006;47:1365-8.

Dunn P. Pseudo-Gaucher cells in mycobacterial infection: a report of two cases. J Clin Pathol. 2005;58:1113-4.

Stewart AJ JR. Pseudo-Gaucher cells in myelodysplasia. J Clin Pathol. 1999;52:917-8.

Carrington PA SR, Lendon M. Pseudo-Gaucher cells. J Clin Pathol. 1992;45:360-1.

Büsche G MH, Schlué J, Delventhal S, et al. Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukemia. Virchow Arch. 1997;430:139-48.

Murugesan V, Chuang W-L, Liu J, et al. Glucosylsphingosine is a key biomarker of Gaucher disease: Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol. 2016;91:1082-9.

Smid BE, van der Tol L, Biegstraaten M, Linthorst GE, CEM H, BJHM P. Plasma lobotriaosylsphingosine about phenotypes of Fabry disease. J Med Genet. 15;52:262-8.

Polo G, Burlina AP, TB K, Zampieri M, et al. Diagnosis of sphingolipidoses: new simultaneous measurement of glycosphingolipids by LC-MS/MS: Clin Chem Lab Med CCLM; 017. Available from: https://www.degruyter.com/doi/10.1515/cclm-2016-0340.

Mashima R, Maekawa M, Narita A, Okuyama T, Mano N. Elevation of plasma lysosphingomyelin-509 and urinary bile acid metabolite in Niemann-Pick disease type C-affected individuals. Mol Genet Metab Rep. 2018;15:90-5.

Phetthong T, Tim-Aroon T, Khongkraparn A, et al. Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients. Orphanet J Rare Dis. 2021;16:519.

Mistry PK, Cappellini MD, Lukina E, et al. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol. 2011;86(1):110-5.

Kaplan P, Baris H, De Meirleir L, et al. Revised recommendations for the management of Gaucher disease in children. Eur J Pediatr. 2013 Apr;172(4):447–58.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.